1. Home
  2. LICN vs XXII Comparison

LICN vs XXII Comparison

Compare LICN & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LICN
  • XXII
  • Stock Information
  • Founded
  • LICN 2004
  • XXII 1998
  • Country
  • LICN China
  • XXII United States
  • Employees
  • LICN N/A
  • XXII N/A
  • Industry
  • LICN
  • XXII Medicinal Chemicals and Botanical Products
  • Sector
  • LICN
  • XXII Health Care
  • Exchange
  • LICN Nasdaq
  • XXII Nasdaq
  • Market Cap
  • LICN 2.1M
  • XXII 2.1M
  • IPO Year
  • LICN 2023
  • XXII N/A
  • Fundamental
  • Price
  • LICN $3.31
  • XXII $1.05
  • Analyst Decision
  • LICN
  • XXII
  • Analyst Count
  • LICN 0
  • XXII 0
  • Target Price
  • LICN N/A
  • XXII N/A
  • AVG Volume (30 Days)
  • LICN 50.3K
  • XXII 654.0K
  • Earning Date
  • LICN 01-01-0001
  • XXII 05-13-2025
  • Dividend Yield
  • LICN N/A
  • XXII N/A
  • EPS Growth
  • LICN N/A
  • XXII N/A
  • EPS
  • LICN N/A
  • XXII N/A
  • Revenue
  • LICN $41,477,000.00
  • XXII $24,382,000.00
  • Revenue This Year
  • LICN N/A
  • XXII $19.23
  • Revenue Next Year
  • LICN N/A
  • XXII $81.05
  • P/E Ratio
  • LICN N/A
  • XXII N/A
  • Revenue Growth
  • LICN 4.32
  • XXII N/A
  • 52 Week Low
  • LICN $0.04
  • XXII $0.70
  • 52 Week High
  • LICN $7.55
  • XXII $226.80
  • Technical
  • Relative Strength Index (RSI)
  • LICN 45.62
  • XXII 46.03
  • Support Level
  • LICN $3.26
  • XXII $0.75
  • Resistance Level
  • LICN $3.96
  • XXII $1.42
  • Average True Range (ATR)
  • LICN 0.39
  • XXII 0.15
  • MACD
  • LICN -0.03
  • XXII 0.09
  • Stochastic Oscillator
  • LICN 3.64
  • XXII 48.47

About LICN Lichen China Limited

Lichen International Ltd formerly Lichen China Ltd is a holding company. The company, along with its subsidiaries provides financial and taxation solution services; education support services; and software and maintenance services. The company generates Majority revenue from Financial and taxation solution services.

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Share on Social Networks: